Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities

American Journal of Hematology

Volumn 78, Issue 1, 2005, Pages 67-70

  Toubai, Tomomi ^a   Tanaka, Junji ^a   Higa, Toshio ^b   Ota, Shuichi ^a   Ibata, Makoto ^a   Shono, Yusuke ^a   Mashiko, Shinobu ^a   Miura, Yoko ^a   Umehara, Shintaro ^a   Kahata, Kaoru ^a   Toyoshima, Nobuyasu ^a   Morioka, Masanobu ^c   Asaka, Masahiro ^a   Kasai, Masaharu ^d   Imamura, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kaisei Hospital   (Japan)

^c JAPANESE RED CROSS SOCIETY   (Japan)

^d SAPPORO HOKUYU HOSPITAL   (Japan)

Author keywords

Cytogenetics; Del 11 (q14q23); Del 13(q12q14); IMF; Micromegakaryocytic leukemia; MMM; Myelofibrosis with myeloid metaplasia; Trisomy 8

Indexed keywords

ACUTE MEGAKARYOCYTIC LEUKEMIA; ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHROMOSOME ARM; CHROMOSOME DELETION; CHROMOSOME DELETION 11; CHROMOSOME DELETION 13; CLINICAL FEATURE; DEATH; DYSPNEA; FEMALE; HEPATOMEGALY; HUMAN; LEUKEMIA; MYELOID METAPLASIA; PRIORITY JOURNAL; SPLENOMEGALY; SYMPTOM; TRISOMY 8;

BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 8; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; GENE DELETION; HUMANS; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA; TRISOMY;

EID: 19944396125     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20254     Document Type: Article

References (24)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255-1265.
2. Mesa RA, Li CY, Schroeder G, Tefferi A. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia. Blood 2001;97:3665-3667.
3. Kutti J, Ridell B. Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis. Pathol Biol 2001;49:164-166.
4. Rozman C, Giralt M, Feliu E, Rubio D, Cortes MT. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991;67:2658-2663.
5. Benbassat J, Penchas S, Ligumski M. Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases. Br J Haematol 1979;42:729-735.
6. Reilly JT, Wilson G, Barnett D, Watmore A, Potter A. Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis. Br J Haematol 1994;88:575-581.
7. Reilly JT, Snowden JA, Spearing RL, Fitzgerald PM, Jones N, Watmore A, Potter A. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br J Haematol 1997;98:96-102.
8. Dupriez B, Morel P, Demory J-L, et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 1996;88:1013-1018.
9. Reilly JT. Cytogenetic and molecular genetic aspects of idiopathic myelofibrosis. Acta Haematol 2002;108:113-119.
10. Musilove J, Michalova K. Chromosome study of 85 patients with myelodysplastic syndrome. Cancer Genet Cytogenet 1988;33:39-50.
11. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-646.
12. Berger R, Bernheim A, Sigaux F, Daniel MT, Valensi F, Flandrin G. Acute monocytic leukemia chromosome studies. Leuk Res 1982;6:17-26.
13. Thirman MJ, Gill HJ, Burnett RC, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid with 11q23 chromosomal translocation. N Engl J Med 1993;329:909-914.
14. Dreyling MH, Martinez-Climent JA, Zheng M, Mao, J, Rowley JD, Bohlander SK. The t(10;11)(P13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci USA 1996;93:4804-4809.
15. Tebar F, Bohlander SK, Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of over-expression on clathrin-mediated traffic. Mol Biol Cell 1999;10:2687-2702.
16. Wechsler DS, Engstrom LD, Alexander BM, Motto DG, Roulston D. A novel chromosomal inversion at 11q23 in infant acute myelogenous leukemia fuses MLL and CALM, a gene that encodes a clathrin assembly protein. Genes Chromosomes Cancer 2003;36:26-36.
17. Cuneo A, Mecucci C, Kerim S, et al. Multipotent stem cell involvement megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients. Blood 1989;74:1781-1790.
18. Tefferi A, Mesa RA, Schroeder G, Hansen CA, Li C-Y, Dewald GW. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Br J Haematol 1994;88:575-581.
19. Amin MB, Maeda K, Carey JL, Babu RV, Raman BK. Megakaryoblastic termination of myeloproliferative disorders. Henry Ford Hosp Med J 1992;40:122-126.
20. Reilly JT, Barnett D, Dolan G, Forrest P, Eastham J, Smith A. Characterization of acute micromegakaryocytic leukemia: evidence for the pathogenesis of myelofibrosis. Br J Haematol 1993;83:58-62.
21. Rosangela I, Pecci A, Formisano R. Micromegakaryocytic transformation of myelofibrosis with myeloid metaplasia. Haematologica 2000;85:98-99.
22. Cortes J, Giles F, O'Brien S, et al. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders. Cancer 2003;97:2760-2766.
23. Tefferi A, Mesa RA, Gray LA, et al. Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia. Blood 2002;99:3854-3856.
24. Hasselbalch HC, Bjerrum OW, Jensen BA, et al. Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis. Am J Hematol 2003;74:238-242.